Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer

NCT03286738 · clinicaltrials.gov ↗
UNKNOWN
Status
1800
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Joong Bae Ahn